| EQA 2027 - Fibrin and fibrinogen degradation products (PDF) |
|---|
|
Expert Biologists - Program Coordinators:
Béatrice GUILLEMIN EQA performed since 2022
Number of analytical sites registered in 2026: 31 |
| Program organised by ProBioQual and placed under the aegis of the FAEEQ |
|
1 – Program overview
This external quality assessment program evaluates the accuracy of assays for detecting and measuring fibrin and fibrinogen degradation products (FDPs) in plasma.
The main commercial reagents are represented, including quantitative and semi-quantitative methods.
Statistical reports are sent with supporting comments from the expert clinical biologists / program coordinators.
2 – Assessment frequency
Number of surveys per year: 4
Number of control samples per survey: 1 or 2
Number of samples per year: 6
3 – List of analytes assessed
4 – Description of the control samples
Lyophilised human control plasma (citrate) (samples to be resuspended in 1 mL of distilled water).
| | Legal notices and privacy policy | General terms of sale | | Last updated: 13 October 2026 | Copyright © 2011-2026 ProBioQual All rights reserved |